Gubra A/S (GUBRA.CO)

DKK 728.0

(2.82%)

Market Cap (In DKK)

11.87 Billion

Revenue (In DKK)

205 Million

Net Income (In DKK)

-44.52 Million

Avg. Volume

75.91 Thousand

Currency
DKK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
114.0-754.0
PE
-
EPS
-
Beta Value
0.0
ISIN
DK0062266474
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Henrik Blou
Employee Count
-
Website
https://www.gubra.dk
Ipo Date
2023-04-04
Details
Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. The CRO segment offers pre-clinical contract research and development services for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, tissue research, assays, molecular pharmacology, bioanalysis, sequencing (NGS), and 2D and 3D imaging. The company was incorporated in 2008 and is based in Horsholm, Denmark.